Annual accounts receivable:
$142.08M-$2.08M(-1.44%)Summary
- As of today (May 29, 2025), SUPN annual accounts receivable is $142.08 million, with the most recent change of -$2.08 million (-1.44%) on December 31, 2024.
- During the last 3 years, SUPN annual accounts receivable has fallen by -$6.86 million (-4.60%).
- SUPN annual accounts receivable is now -14.15% below its all-time high of $165.50 million, reached on December 31, 2022.
Performance
SUPN Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$145.64M+$3.56M(+2.51%)Summary
- As of today (May 29, 2025), SUPN quarterly accounts receivable is $145.64 million, with the most recent change of +$3.56 million (+2.51%) on March 31, 2025.
- Over the past year, SUPN quarterly accounts receivable has dropped by -$2.09 million (-1.42%).
- SUPN quarterly accounts receivable is now -12.00% below its all-time high of $165.50 million, reached on December 31, 2022.
Performance
SUPN Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SUPN Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | -1.4% |
| 3 y3 years | -4.6% | +0.3% |
| 5 y5 years | +62.7% | +22.2% |
SUPN Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.2% | at low | -12.0% | +6.7% |
| 5 y | 5-year | -14.2% | +62.7% | -12.0% | +22.2% |
| alltime | all time | -14.2% | >+9999.0% | -12.0% | >+9999.0% |
SUPN Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $145.64M(+2.5%) |
| Dec 2024 | $142.08M(-1.4%) | $142.08M(-2.3%) |
| Sep 2024 | - | $145.41M(-4.6%) |
| Jun 2024 | - | $152.49M(+3.2%) |
| Mar 2024 | - | $147.73M(+2.5%) |
| Dec 2023 | $144.16M(-12.9%) | $144.16M(+1.7%) |
| Sep 2023 | - | $141.76M(+3.8%) |
| Jun 2023 | - | $136.56M(-4.9%) |
| Mar 2023 | - | $143.57M(-13.3%) |
| Dec 2022 | $165.50M(+11.1%) | $165.50M(+0.9%) |
| Sep 2022 | - | $164.09M(+3.8%) |
| Jun 2022 | - | $158.06M(+8.9%) |
| Mar 2022 | - | $145.15M(-2.5%) |
| Dec 2021 | $148.93M(+5.7%) | $148.93M(+11.4%) |
| Sep 2021 | - | $133.68M(-2.6%) |
| Jun 2021 | - | $137.28M(+8.0%) |
| Mar 2021 | - | $127.06M(-9.8%) |
| Dec 2020 | $140.88M(+61.3%) | $140.88M(+5.8%) |
| Sep 2020 | - | $133.11M(+5.2%) |
| Jun 2020 | - | $126.56M(+6.2%) |
| Mar 2020 | - | $119.19M(+36.5%) |
| Dec 2019 | $87.33M(-15.1%) | $87.33M(+0.7%) |
| Sep 2019 | - | $86.70M(+2.5%) |
| Jun 2019 | - | $84.56M(+5.8%) |
| Mar 2019 | - | $79.95M(-22.3%) |
| Dec 2018 | $102.92M | $102.92M(+32.4%) |
| Sep 2018 | - | $77.75M(+3.9%) |
| Jun 2018 | - | $74.84M(+10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $67.86M(+3.5%) |
| Dec 2017 | $65.59M(+57.9%) | $65.59M(+16.8%) |
| Sep 2017 | - | $56.17M(+9.8%) |
| Jun 2017 | - | $51.16M(+31.6%) |
| Mar 2017 | - | $38.88M(-6.4%) |
| Dec 2016 | $41.53M(+60.3%) | $41.53M(+14.7%) |
| Sep 2016 | - | $36.22M(+5.7%) |
| Jun 2016 | - | $34.28M(+11.8%) |
| Mar 2016 | - | $30.65M(+18.3%) |
| Dec 2015 | $25.91M(+50.0%) | $25.91M(+9.8%) |
| Sep 2015 | - | $23.60M(+31.9%) |
| Jun 2015 | - | $17.90M(-7.1%) |
| Mar 2015 | - | $19.27M(+11.6%) |
| Dec 2014 | $17.27M(+241.7%) | $17.27M(+12.9%) |
| Sep 2014 | - | $15.30M(+41.0%) |
| Jun 2014 | - | $10.85M(+11.6%) |
| Mar 2014 | - | $9.72M(+92.4%) |
| Dec 2013 | $5.05M(>+9900.0%) | $5.05M(-29.9%) |
| Sep 2013 | - | $7.21M(+1242.3%) |
| Jun 2013 | - | $537.00K(-67.5%) |
| Mar 2013 | - | $1.65M(>+9900.0%) |
| Dec 2012 | $11.00K(>+9900.0%) | $11.00K(-97.8%) |
| Sep 2012 | - | $500.00K(>+9900.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2011 | - | $3.98M(+8940.9%) |
| Dec 2010 | $44.00K(-98.7%) | $44.00K(-98.5%) |
| Sep 2010 | - | $3.03M(-11.0%) |
| Dec 2009 | $3.41M(+49.7%) | $3.41M |
| Dec 2008 | $2.28M | - |
FAQ
- What is Supernus Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual accounts receivable year-on-year change?
- What is Supernus Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Supernus Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of SUPN is $142.08M
What is the all time high annual accounts receivable for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual accounts receivable is $165.50M
What is Supernus Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, SUPN annual accounts receivable has changed by -$2.08M (-1.44%)
What is Supernus Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of SUPN is $145.64M
What is the all time high quarterly accounts receivable for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly accounts receivable is $165.50M
What is Supernus Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, SUPN quarterly accounts receivable has changed by -$2.09M (-1.42%)